Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling.
Misfiring in multiple sclerosis: Cerebellar Channelopathy, a Potential Novel Target?
Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Multiple sclerosis in a postgraduate student of anaesthesia: illness in doctors and fitness to practice.
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
[Disease-modifying drugs in pediatric patients with multiple sclerosis].
Downmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNS.
Deletion of jun proteins in adult oligodendrocytes does not perturb cell survival, or myelin maintenance in vivo.
Corticospinal tract integrity is related to primary motor cortex thinning in relapsing-remitting multiple sclesis.
Microglia-derived IL-1β triggers p53-mediated cell cycle arrest and apoptosis in neural precursor cells.
5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly¬(ADP Ribose)¬Polymerases (PARPs).
A rare case of nonenhancing primary central nervous system lymphoma mimic multiple sclerosis.
Characteristics of Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States.
Effectiveness of rehabilitation in multiple sclerosis relapse on fatigue, self-efficacy and physical activity.
Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis.
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
Epidemiology and Current Treatment of Neuromyelitis Optica: A Systematic Review.
Neuroinflammation: A common denominator for stroke, multiple sclerosis and Alzheimer's disease.
Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis.
Diaphragm Breathing Movement Measurement using Ultrasound and Radiographic Imaging: A Concurrent Validity.
[Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Con.]
Mutagenesis of the Aquaporin 4 Extracellular Domains Defines Restricted Binding Patterns of Pathogenic Neuromyelitis Optica IgG.
Hilbert-Huang transform based instrumental assessment of intention tremor in multiple sclerosis.
Pages
« first
‹ previous
…
705
706
707
708
709
710
711
712
713
…
next ›
last »